IN2014CH01890A - - Google Patents

Download PDF

Info

Publication number
IN2014CH01890A
IN2014CH01890A IN1890CH2014A IN2014CH01890A IN 2014CH01890 A IN2014CH01890 A IN 2014CH01890A IN 1890CH2014 A IN1890CH2014 A IN 1890CH2014A IN 2014CH01890 A IN2014CH01890 A IN 2014CH01890A
Authority
IN
India
Prior art keywords
sterile formulation
preparation
same
sterile
formulation
Prior art date
Application number
Inventor
Arvind Gannimitta
Sachin Jain
Sagar Rase
Jayant Karajgi
Sivakumaran Meenakshisunderam
Original Assignee
Aurobindo Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aurobindo Pharma Ltd filed Critical Aurobindo Pharma Ltd
Priority to IN1890CH2014 priority Critical patent/IN2014CH01890A/en
Priority to US14/683,105 priority patent/US20150290220A1/en
Publication of IN2014CH01890A publication Critical patent/IN2014CH01890A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions

Abstract

Sterile formulation comprising glucocorticosteroids, process for the preparation of the sterile formulation and method of using the same are provided. The present invention also relates to sterile formulation comprising budesonide, process for the preparation of the sterile formulation and method of using the same.
IN1890CH2014 2014-04-10 2014-04-10 IN2014CH01890A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN1890CH2014 IN2014CH01890A (en) 2014-04-10 2014-04-10
US14/683,105 US20150290220A1 (en) 2014-04-10 2015-04-09 Pharmaceutical formualtions comprising a Gluococorticosteroid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1890CH2014 IN2014CH01890A (en) 2014-04-10 2014-04-10

Publications (1)

Publication Number Publication Date
IN2014CH01890A true IN2014CH01890A (en) 2015-10-16

Family

ID=54264158

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1890CH2014 IN2014CH01890A (en) 2014-04-10 2014-04-10

Country Status (2)

Country Link
US (1) US20150290220A1 (en)
IN (1) IN2014CH01890A (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2318145T3 (en) * 2002-02-19 2009-05-01 Resolution Chemicals Limited STEROIDS STERILIZATION THROUGH SOLVENTS.
DE10214002A1 (en) * 2002-03-27 2003-10-09 Roehm Gmbh Pharmaceutical formulation for the active substance budesonide
GB0425266D0 (en) * 2004-11-16 2004-12-15 Norton Healthcare Ltd Pharmaceutical manufacturing process

Also Published As

Publication number Publication date
US20150290220A1 (en) 2015-10-15

Similar Documents

Publication Publication Date Title
MX2023008686A (en) Modulatory polynucleotides.
WO2015117081A3 (en) Methods and compositions for treatment of a beta thalessemia
EP3800248A3 (en) Crispr-cas-related methods, compositions and components for cancer immunotherapy
MY192927A (en) Fused bicyclic compounds for the treatment of disease
MX2017008456A (en) Fused bicyclic compounds for the treatment of disease.
PH12017500239A1 (en) Abiraterone acetate formulation and methods of use
EP3179993A4 (en) Method for the treatment of depression
EP3166931A4 (en) An improved process for the preparation of enzalutamide
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
EP3373910A4 (en) Echinomycin formulation, method of making and method of use thereof
EP3280408A4 (en) Process for the preparation of dicycloplatin
EP3227298A4 (en) Process for the preparation of baricitinib and an intermediate thereof
ZA201703467B (en) Methods of treating ocular conditions
IN2014CH00840A (en)
EP3169405A4 (en) Methods, compounds, and compositions for the treatment of musculoskeletal diseases
EP3148540A4 (en) Process for the preparation of cyclic depsipeptides
SG10201908248PA (en) Processes for preparing fluoroketolides
EP3174991A4 (en) Methods, compositions, and kits for analysis of structurally diverse complex lipids
EP3386944A4 (en) Process for preparation of lisdexamphetamine
NZ721832A (en) Solid forms of tenofovir
GB2561089B (en) Process for the preparation of 17beta-hydroxy-des-a-androst-9, 10-en-5-one
EP3142999A4 (en) Methods and compositions of dasotraline for treatment of adhd
IN2014CH01890A (en)
IL249297A0 (en) Devices and kits for production of personalized, concentrated human milk compositions, and methods of making and using same
EP3303345A4 (en) Ertugliflozin co-crystals and process for their preparation